Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Immunoglobulin Light-chain Amyloidosis 1Amyloidosis 1

Interventions

Cyclophosphamide 4Dexamethasone 3sargramostim 2Bortezomib 2pomalidomide 1isatuximab 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Thalidomide 1Technetium Tc 99m Pyrophosphate 1Technetium 1Registries 1Radiotherapy 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Lenalidomide 1Ketamine 1Filgrastim 1Carboplatin 1Calcium Dobesilate 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Immunoglobulin Light-chain Amyloidosis × Technetium × Clear all
NCT05951816 2023-07-19

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

University of Tennessee Graduate School of Medicine

Phase 1 Unknown
35 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡